Drug Monitoring Is Inadequate, Physicians Report
Prescription drug recalls have shaken the confidence of consumers. More importantly, they have also shaken doctors in the post-marketing tracking of prescription drugs. Electronic medical records may be the solution. (CIOInsight.com)
A recent study by industry consultancy Accenture found that about two-thirds of doctors and one-third of consumers have become more concerned about the safety of prescription medications since the recent removal from the market of popular pain relievers known as COX-2 inhibitors. The survey also found that the vast majority of physicians and consumers believe that more should be done to monitor the safety of drugs after they are on the market. Eight in 10 physicians said regulatory agencies should increase monitoring after drugs are approved for use, and more than three-quarters said regulatory agencies should improve monitoring feedback capabilities.Only one-third of physicians said they were extremely or very confident in the current post-market monitoring system.
Click here to read more about a survey that found wide enthusiasm for EMRs.
George expects to see state and regional electronic medical records emerging in the next two to three years and a national one in about a decade.
Before that can come about, though, "we need common standards so that all the information can be put into a single system in a readable, usable format, and you need analysis tools to mine the database," George said.
A more intermediate solution is to query the databases of the big health plans.
Read the full story on CIOInsight.com: Drug Monitoring Is Inadequate, Physicians Report
Check out eWEEK.coms for the latest news, views and analysis of technologys impact on health care. 








